ilmscore | Prediction Details
"Chronic share percentage for Mankind Pharma has been continuously increasing from 22 to 24 where their share has increased from 33 to 34 and now at 36."
By CA Rachana Phadke Ranade | January 22, 2025 | Pending
From video
Mankind Pharma: Fundamental Analysis | Stocks in Focus - Part 3 | CA Rachana Ranade 00:09:00 - 00:09:07
Interpreted Prediction
Mankind Pharma's market share in the chronic disease segment has grown from 33% in FY22 to 36% in FY24.

Prediction Details

Ticker
MANKIND

Comments

0 comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.